Загрузка...
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
Vaccination against SARS-CoV-2 has become available and will hopefully end the current pandemic. Understandably, patients with inflammatory rheumatic diseases (iRMDs) and their physicians are feverishly preoccupied with questions about vaccination and the vaccines against SARS-CoV-2. However, as it...
Сохранить в:
| Опубликовано в: : | RMD Open |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907835/ https://ncbi.nlm.nih.gov/pubmed/33627439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|